CUSIP: 30233M107
Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,266,351
-
Share change
-
+379,756
-
Total reported value
-
$5,571,000
-
Price per share
-
$0.30
-
Number of holders
-
13
-
Value change
-
+$112,612
-
Number of buys
-
3
-
Number of sells
-
5
Quarterly Holders Quick Answers
What is CUSIP 30233M107?
CUSIP 30233M107 identifies EYEG - EYEGATE PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2019
-
Previous quarter:
Q4 2018
Recent filing periods for CUSIP 30233M107:
Institutional Holders of EYEGATE PHARMACEUTICALS INC - COM (EYEG) as of Q1 2019
As of 31 Mar 2019,
EYEGATE PHARMACEUTICALS INC - COM (EYEG) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,266,351 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, PANAGORA ASSET MANAGEMENT INC, Virtu Financial LLC, US BANCORP \DE\, Golden State Wealth Management, LLC, Advisor Group, Inc., WEDBUSH SECURITIES INC, NORTHERN TRUST CORP, and ROYAL BANK OF CANADA.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.